COSTARELLI, Sandro
 Distribuzione geografica
Continente #
NA - Nord America 89
AS - Asia 38
EU - Europa 24
AF - Africa 11
SA - Sud America 10
OC - Oceania 1
Totale 173
Nazione #
US - Stati Uniti d'America 88
SG - Singapore 21
CN - Cina 13
IT - Italia 12
BR - Brasile 10
CM - Camerun 9
DE - Germania 4
AT - Austria 3
BG - Bulgaria 1
GB - Regno Unito 1
IN - India 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TN - Tunisia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 173
Città #
Singapore 16
Chandler 15
Ashburn 9
Santa Clara 9
Beijing 8
Ferrara 6
Wilmington 5
Princeton 4
Redwood City 4
Pau dos Ferros 3
Shanghai 3
Boardman 2
Bologna 2
Los Angeles 2
Vienna 2
Washington 2
Almaty 1
Bremen 1
Cambridge 1
Christchurch 1
Contagem 1
Falkenstein 1
Frankfurt am Main 1
Houghton 1
Houston 1
Istanbul 1
Joinville 1
Lages 1
London 1
Milan 1
Mountain View 1
New Delhi 1
Norwalk 1
Nova Pazova 1
Oslo 1
Sofia 1
Sumaré 1
São Pedro 1
Taizhou 1
Toluca 1
Tunis 1
Zhengzhou 1
Totale 118
Nome #
Atazanavir/rit(atz/r),unboosted atazanavir (atz) or darunavir/rit(drv/r):metabolic safety and liver fibrosis in hiv/hcv coinfected patients (master cohort) 78
Factors that influence HCV related liver disease severity in Italian patients in care: data from PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti ViRali) HCV cohort study". 56
Antiretroviral Regimens Containing Atazanavir/Ritonavir (ATZ/R) Unboosted Atazanavir (ATZ) or Darunavir/Ritonavir (DRV/R) in HIV/HCV-coinfected Patients: Evaluation of Safety, Effectivness And Impact on Liver Fibrosis (MASTER Cohort) 52
Totale 186
Categoria #
all - tutte 1.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 0 0 8 16 1 0
2020/202111 0 5 2 0 0 0 0 0 1 2 1 0
2021/202225 0 3 0 0 0 0 0 0 2 7 1 12
2022/202330 3 3 3 1 4 4 1 3 5 0 2 1
2023/202426 2 0 2 1 3 6 0 1 2 1 0 8
2024/202569 3 1 5 8 7 13 3 11 18 0 0 0
Totale 186